platelet factor 4 Search Results


94
Athens Research platelet factor 4 pf 4
HBS of protect and label strategy test proteins The HBSs and the methods used to identify these are given. SDM, site-directed mutagenesis; x-ray, x-ray crystallography; SP, synthetic peptide; MM, molecular modeling.
Platelet Factor 4 Pf 4, supplied by Athens Research, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/Platelet+Factor+4/pmc02758754-82-0-13
Average 94 stars, based on 1 article reviews
platelet factor 4 pf 4 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Cusabio e07884m
HBS of protect and label strategy test proteins The HBSs and the methods used to identify these are given. SDM, site-directed mutagenesis; x-ray, x-ray crystallography; SP, synthetic peptide; MM, molecular modeling.
E07884m, supplied by Cusabio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/Mouse+Platelet+Factor+4%2CPF-4+ELISA+Kit/pm42776840-801-24-28
Average 94 stars, based on 1 article reviews
e07884m - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Elabscience Biotechnology pf4 elisa kit
Fig. 3 <t>PF4</t> induces NET formation in CVST patients. a NPAs (CD41+/CD66b+) were examined in samples from healthy controls (n = 20) and CVST (n = 17) patients. b–e Neutrophils (from healthy people) were incubated with PRP from patients and healthy subjects and stained with CD41 (red) and MPO (green) to show the colocalization of NETs and PLTs. f Neutrophils (from CVST patients) were incubated with PRP from healthy subjects and stained with CD41 (red) and MPO (green). g Plasma PF4 levels were measured in samples from CVST patients (n = 37) and healthy subjects (n = 32). h Control neutrophils were treated with different concentrations of recombinant PF4 protein. CitH3-DNA was measured in each group (n = 10). Control neutrophils were incubated with PRP from healthy subjects and CVST patients in the presence of anti-PF4 antibodies. i NET releasing neutrophils (citH3 + Neut) was measured in cells from each group by flow cytometry. j–o Neutrophils were stained with MPO (red) and citH3 (green). Statistics: Ordinary one-way ANOVA (a, g); Brown-Forsythe and Welch’s ANOVA test (f, h, i). The inset scale bars are 20 μm in b–e, j–o. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Neut, Neutrophils
Pf4 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/Porcine+PF4+(Platelet+Factor+4)+ELISA+Kit/pm35869501-97-21-24
Average 90 stars, based on 1 article reviews
pf4 elisa kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Elabscience Biotechnology mouse pf4 elisa kit
Fig. 3 <t>PF4</t> induces NET formation in CVST patients. a NPAs (CD41+/CD66b+) were examined in samples from healthy controls (n = 20) and CVST (n = 17) patients. b–e Neutrophils (from healthy people) were incubated with PRP from patients and healthy subjects and stained with CD41 (red) and MPO (green) to show the colocalization of NETs and PLTs. f Neutrophils (from CVST patients) were incubated with PRP from healthy subjects and stained with CD41 (red) and MPO (green). g Plasma PF4 levels were measured in samples from CVST patients (n = 37) and healthy subjects (n = 32). h Control neutrophils were treated with different concentrations of recombinant PF4 protein. CitH3-DNA was measured in each group (n = 10). Control neutrophils were incubated with PRP from healthy subjects and CVST patients in the presence of anti-PF4 antibodies. i NET releasing neutrophils (citH3 + Neut) was measured in cells from each group by flow cytometry. j–o Neutrophils were stained with MPO (red) and citH3 (green). Statistics: Ordinary one-way ANOVA (a, g); Brown-Forsythe and Welch’s ANOVA test (f, h, i). The inset scale bars are 20 μm in b–e, j–o. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Neut, Neutrophils
Mouse Pf4 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/Mouse+PF4+(Platelet+Factor+4)+ELISA+Kit/pm41677949-232-8-12
Average 94 stars, based on 1 article reviews
mouse pf4 elisa kit - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Proteintech anti cxcl4
Fig. 3 <t>PF4</t> induces NET formation in CVST patients. a NPAs (CD41+/CD66b+) were examined in samples from healthy controls (n = 20) and CVST (n = 17) patients. b–e Neutrophils (from healthy people) were incubated with PRP from patients and healthy subjects and stained with CD41 (red) and MPO (green) to show the colocalization of NETs and PLTs. f Neutrophils (from CVST patients) were incubated with PRP from healthy subjects and stained with CD41 (red) and MPO (green). g Plasma PF4 levels were measured in samples from CVST patients (n = 37) and healthy subjects (n = 32). h Control neutrophils were treated with different concentrations of recombinant PF4 protein. CitH3-DNA was measured in each group (n = 10). Control neutrophils were incubated with PRP from healthy subjects and CVST patients in the presence of anti-PF4 antibodies. i NET releasing neutrophils (citH3 + Neut) was measured in cells from each group by flow cytometry. j–o Neutrophils were stained with MPO (red) and citH3 (green). Statistics: Ordinary one-way ANOVA (a, g); Brown-Forsythe and Welch’s ANOVA test (f, h, i). The inset scale bars are 20 μm in b–e, j–o. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Neut, Neutrophils
Anti Cxcl4, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/PF4+Antibody/pmc10996374-60-34-36
Average 93 stars, based on 1 article reviews
anti cxcl4 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cusabio human platelet factor 4 pf4 elisa kit
Fig. 3 <t>PF4</t> induces NET formation in CVST patients. a NPAs (CD41+/CD66b+) were examined in samples from healthy controls (n = 20) and CVST (n = 17) patients. b–e Neutrophils (from healthy people) were incubated with PRP from patients and healthy subjects and stained with CD41 (red) and MPO (green) to show the colocalization of NETs and PLTs. f Neutrophils (from CVST patients) were incubated with PRP from healthy subjects and stained with CD41 (red) and MPO (green). g Plasma PF4 levels were measured in samples from CVST patients (n = 37) and healthy subjects (n = 32). h Control neutrophils were treated with different concentrations of recombinant PF4 protein. CitH3-DNA was measured in each group (n = 10). Control neutrophils were incubated with PRP from healthy subjects and CVST patients in the presence of anti-PF4 antibodies. i NET releasing neutrophils (citH3 + Neut) was measured in cells from each group by flow cytometry. j–o Neutrophils were stained with MPO (red) and citH3 (green). Statistics: Ordinary one-way ANOVA (a, g); Brown-Forsythe and Welch’s ANOVA test (f, h, i). The inset scale bars are 20 μm in b–e, j–o. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Neut, Neutrophils
Human Platelet Factor 4 Pf4 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/Human+Platelet+Factor+4%2CPF-4+ELISA+Kit/bio_rxiv__2022__11__29__518340-47-0-9
Average 93 stars, based on 1 article reviews
human platelet factor 4 pf4 elisa kit - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Creative BioMart human platelet factor 4
Fig. 3 <t>PF4</t> induces NET formation in CVST patients. a NPAs (CD41+/CD66b+) were examined in samples from healthy controls (n = 20) and CVST (n = 17) patients. b–e Neutrophils (from healthy people) were incubated with PRP from patients and healthy subjects and stained with CD41 (red) and MPO (green) to show the colocalization of NETs and PLTs. f Neutrophils (from CVST patients) were incubated with PRP from healthy subjects and stained with CD41 (red) and MPO (green). g Plasma PF4 levels were measured in samples from CVST patients (n = 37) and healthy subjects (n = 32). h Control neutrophils were treated with different concentrations of recombinant PF4 protein. CitH3-DNA was measured in each group (n = 10). Control neutrophils were incubated with PRP from healthy subjects and CVST patients in the presence of anti-PF4 antibodies. i NET releasing neutrophils (citH3 + Neut) was measured in cells from each group by flow cytometry. j–o Neutrophils were stained with MPO (red) and citH3 (green). Statistics: Ordinary one-way ANOVA (a, g); Brown-Forsythe and Welch’s ANOVA test (f, h, i). The inset scale bars are 20 μm in b–e, j–o. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Neut, Neutrophils
Human Platelet Factor 4, supplied by Creative BioMart, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/Human+Platelet+Factor+4/pmc08395316-54-34-38
Average 92 stars, based on 1 article reviews
human platelet factor 4 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

92
MedChemExpress recombinant mouse pf4 protein
C5ar1 knockdown in CD45 + brown adipocytes promote <t>PF4</t> release to inhibit brown adipocyte maturation (A) Relative mRNA expression of the cytokines genes ( Pf4 , Ccl3 , Ccl4 , Ccl12 ) of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 6). (B) The concentration of PF4 in the supernatant of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 3). (C) Pf4 mRNA expression in differentiated CD45 − and CD45 + adipocytes ( n = 6). (D) Concentration of PF4 in the supernatant of differentiated CD45 − and CD45 + adipocytes ( n = 3). (E) Pf4 mRNA expression of BAT from Control and C5ar1 AKO neonatal mice ( n = 8). (F) Concentration of PF4 in BAT of Control and C5ar1 AKO neonatal mice ( n = 6). (G) Relative mRNA expression of the indicated genes of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 6). (H) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 3). (I) Relative mRNA expression of the indicated genes from adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (J) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (K) Graphical abstract of this study: The loss of C5ar1 in CD45 + adipocytes increased Pf4 mRNA level and increased the secretion of PF4. PF4 inhibited the maturity and thermogenesis ability of both CD45 + and CD45 − adipocytes. Statistical significance was assessed by two-tailed Student’s t test (A–G) or one-way ANOVA (I). Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.
Recombinant Mouse Pf4 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/PF-4%2FCXCL4%2C+Mouse/pmc11700647-19-0-5
Average 92 stars, based on 1 article reviews
recombinant mouse pf4 protein - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Elabscience Biotechnology human pf4 platelet factor 4 elisa kit
C5ar1 knockdown in CD45 + brown adipocytes promote <t>PF4</t> release to inhibit brown adipocyte maturation (A) Relative mRNA expression of the cytokines genes ( Pf4 , Ccl3 , Ccl4 , Ccl12 ) of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 6). (B) The concentration of PF4 in the supernatant of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 3). (C) Pf4 mRNA expression in differentiated CD45 − and CD45 + adipocytes ( n = 6). (D) Concentration of PF4 in the supernatant of differentiated CD45 − and CD45 + adipocytes ( n = 3). (E) Pf4 mRNA expression of BAT from Control and C5ar1 AKO neonatal mice ( n = 8). (F) Concentration of PF4 in BAT of Control and C5ar1 AKO neonatal mice ( n = 6). (G) Relative mRNA expression of the indicated genes of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 6). (H) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 3). (I) Relative mRNA expression of the indicated genes from adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (J) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (K) Graphical abstract of this study: The loss of C5ar1 in CD45 + adipocytes increased Pf4 mRNA level and increased the secretion of PF4. PF4 inhibited the maturity and thermogenesis ability of both CD45 + and CD45 − adipocytes. Statistical significance was assessed by two-tailed Student’s t test (A–G) or one-way ANOVA (I). Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.
Human Pf4 Platelet Factor 4 Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/Human%3FPF4+(Platelet%3FFactor%3F4)%3FELISA%3FKit/pmc12657974-106-17-16
Average 93 stars, based on 1 article reviews
human pf4 platelet factor 4 elisa kit - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

91
Elabscience Biotechnology human pf4v1
C5ar1 knockdown in CD45 + brown adipocytes promote <t>PF4</t> release to inhibit brown adipocyte maturation (A) Relative mRNA expression of the cytokines genes ( Pf4 , Ccl3 , Ccl4 , Ccl12 ) of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 6). (B) The concentration of PF4 in the supernatant of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 3). (C) Pf4 mRNA expression in differentiated CD45 − and CD45 + adipocytes ( n = 6). (D) Concentration of PF4 in the supernatant of differentiated CD45 − and CD45 + adipocytes ( n = 3). (E) Pf4 mRNA expression of BAT from Control and C5ar1 AKO neonatal mice ( n = 8). (F) Concentration of PF4 in BAT of Control and C5ar1 AKO neonatal mice ( n = 6). (G) Relative mRNA expression of the indicated genes of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 6). (H) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 3). (I) Relative mRNA expression of the indicated genes from adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (J) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (K) Graphical abstract of this study: The loss of C5ar1 in CD45 + adipocytes increased Pf4 mRNA level and increased the secretion of PF4. PF4 inhibited the maturity and thermogenesis ability of both CD45 + and CD45 − adipocytes. Statistical significance was assessed by two-tailed Student’s t test (A–G) or one-way ANOVA (I). Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.
Human Pf4v1, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/Human+PF4V1+(Platelet+Factor+4+Variant+1)+CLIA+Kit/pm37708957-115-9-17
Average 91 stars, based on 1 article reviews
human pf4v1 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
MedChemExpress human
C5ar1 knockdown in CD45 + brown adipocytes promote <t>PF4</t> release to inhibit brown adipocyte maturation (A) Relative mRNA expression of the cytokines genes ( Pf4 , Ccl3 , Ccl4 , Ccl12 ) of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 6). (B) The concentration of PF4 in the supernatant of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 3). (C) Pf4 mRNA expression in differentiated CD45 − and CD45 + adipocytes ( n = 6). (D) Concentration of PF4 in the supernatant of differentiated CD45 − and CD45 + adipocytes ( n = 3). (E) Pf4 mRNA expression of BAT from Control and C5ar1 AKO neonatal mice ( n = 8). (F) Concentration of PF4 in BAT of Control and C5ar1 AKO neonatal mice ( n = 6). (G) Relative mRNA expression of the indicated genes of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 6). (H) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 3). (I) Relative mRNA expression of the indicated genes from adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (J) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (K) Graphical abstract of this study: The loss of C5ar1 in CD45 + adipocytes increased Pf4 mRNA level and increased the secretion of PF4. PF4 inhibited the maturity and thermogenesis ability of both CD45 + and CD45 − adipocytes. Statistical significance was assessed by two-tailed Student’s t test (A–G) or one-way ANOVA (I). Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.
Human, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/PF-4%2FCXCL4%2C+Human/pm40818452-613-63-66
Average 93 stars, based on 1 article reviews
human - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Elabscience Biotechnology human pf4 elisa
( A , B ) Megakaryocytes isolated from mice bone marrow, and infected with DENV2 (MOI ~ 1) for 24 h with and without 7D. Culture supernatant was used for measuring ( A ) CXCL4 levels using <t>ELISA,</t> and ( B ) cell pallet was used for detecting viral genome using qRT PCR, n = 3 independent experiments for both ( P values: A : 0.0002; 0.04, B : 0.0002; 0.008). ( C , D ) Similar experiment was performed in monocytes (as CXCL4 non-producing cells) isolated from whole blood of these mice. ( C ) CXCL4 and ( D ) DENV2 genome were detected, n = 3 independent experiments for both assays ( P value: 0.0002). A similar experiment was performed in ( E , F ) human MEG-01 cell line (CXCL4 producing cells), n = 3 independent experiments ( P values: E : 0.0008; 0.01, F : 0.006) and ( G , H ) U937-DC-SIGN cell line (CXCL4 non-producing cells), n = 3 independent experiments for above assays. One-way ANOVA and Bonferroni’s post-test were used for data analysis. Data information: ( A – E , G ) One-way ANOVA and Bonferroni’s post-test were used for data analysis. Data are mean ± SEM. ( F , H ) Student’s t-test was used. Data are mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns=non-significant.
Human Pf4 Elisa, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/platelet+factor+4/Uncoated+Human+PF4+(Platelet+Factor+4)+ELISA+Kit/pmc11473809-410-0-3
Average 92 stars, based on 1 article reviews
human pf4 elisa - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

Image Search Results


HBS of protect and label strategy test proteins The HBSs and the methods used to identify these are given. SDM, site-directed mutagenesis; x-ray, x-ray crystallography; SP, synthetic peptide; MM, molecular modeling.

Journal: Molecular & Cellular Proteomics : MCP

Article Title: Identification of Heparin-binding Sites in Proteins by Selective Labeling *

doi: 10.1074/mcp.M900031-MCP200

Figure Lengend Snippet: HBS of protect and label strategy test proteins The HBSs and the methods used to identify these are given. SDM, site-directed mutagenesis; x-ray, x-ray crystallography; SP, synthetic peptide; MM, molecular modeling.

Article Snippet: Platelet factor-4 (PF-4) (Swiss-Prot accession number P02776 ) (residues 32–101) was purchased from Athens Research and Technology Inc. (Athens, GA).

Techniques: Mutagenesis, Structural Proteomics

Fig. 3 PF4 induces NET formation in CVST patients. a NPAs (CD41+/CD66b+) were examined in samples from healthy controls (n = 20) and CVST (n = 17) patients. b–e Neutrophils (from healthy people) were incubated with PRP from patients and healthy subjects and stained with CD41 (red) and MPO (green) to show the colocalization of NETs and PLTs. f Neutrophils (from CVST patients) were incubated with PRP from healthy subjects and stained with CD41 (red) and MPO (green). g Plasma PF4 levels were measured in samples from CVST patients (n = 37) and healthy subjects (n = 32). h Control neutrophils were treated with different concentrations of recombinant PF4 protein. CitH3-DNA was measured in each group (n = 10). Control neutrophils were incubated with PRP from healthy subjects and CVST patients in the presence of anti-PF4 antibodies. i NET releasing neutrophils (citH3 + Neut) was measured in cells from each group by flow cytometry. j–o Neutrophils were stained with MPO (red) and citH3 (green). Statistics: Ordinary one-way ANOVA (a, g); Brown-Forsythe and Welch’s ANOVA test (f, h, i). The inset scale bars are 20 μm in b–e, j–o. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Neut, Neutrophils

Journal: Cell & bioscience

Article Title: Neutrophil extracellular traps promote thrombogenicity in cerebral venous sinus thrombosis.

doi: 10.1186/s13578-022-00845-z

Figure Lengend Snippet: Fig. 3 PF4 induces NET formation in CVST patients. a NPAs (CD41+/CD66b+) were examined in samples from healthy controls (n = 20) and CVST (n = 17) patients. b–e Neutrophils (from healthy people) were incubated with PRP from patients and healthy subjects and stained with CD41 (red) and MPO (green) to show the colocalization of NETs and PLTs. f Neutrophils (from CVST patients) were incubated with PRP from healthy subjects and stained with CD41 (red) and MPO (green). g Plasma PF4 levels were measured in samples from CVST patients (n = 37) and healthy subjects (n = 32). h Control neutrophils were treated with different concentrations of recombinant PF4 protein. CitH3-DNA was measured in each group (n = 10). Control neutrophils were incubated with PRP from healthy subjects and CVST patients in the presence of anti-PF4 antibodies. i NET releasing neutrophils (citH3 + Neut) was measured in cells from each group by flow cytometry. j–o Neutrophils were stained with MPO (red) and citH3 (green). Statistics: Ordinary one-way ANOVA (a, g); Brown-Forsythe and Welch’s ANOVA test (f, h, i). The inset scale bars are 20 μm in b–e, j–o. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001. Neut, Neutrophils

Article Snippet: PF4, thrombin-antithrombin (TAT) complex and von Willebrand factor (VWF) in plasma samples were detected by TAT complex ELISA kit (Elabscience, Shanghai), PF4 ELISA kit (Elabscience, Shanghai) and vWF ELISA kit (Elabscience, Shanghai), respectively.

Techniques: Incubation, Staining, Clinical Proteomics, Control, Recombinant, Flow Cytometry

Fig. 4 NET markers were colocalized with autophagy associated protein. a–c CVST thrombi were stained with CD66b (red), citH3 (green), PF4 (pink), Beclin-1 (pink) and LC3B (pink). The inset scale bars are 20 μm in a-c

Journal: Cell & bioscience

Article Title: Neutrophil extracellular traps promote thrombogenicity in cerebral venous sinus thrombosis.

doi: 10.1186/s13578-022-00845-z

Figure Lengend Snippet: Fig. 4 NET markers were colocalized with autophagy associated protein. a–c CVST thrombi were stained with CD66b (red), citH3 (green), PF4 (pink), Beclin-1 (pink) and LC3B (pink). The inset scale bars are 20 μm in a-c

Article Snippet: PF4, thrombin-antithrombin (TAT) complex and von Willebrand factor (VWF) in plasma samples were detected by TAT complex ELISA kit (Elabscience, Shanghai), PF4 ELISA kit (Elabscience, Shanghai) and vWF ELISA kit (Elabscience, Shanghai), respectively.

Techniques: Staining

C5ar1 knockdown in CD45 + brown adipocytes promote PF4 release to inhibit brown adipocyte maturation (A) Relative mRNA expression of the cytokines genes ( Pf4 , Ccl3 , Ccl4 , Ccl12 ) of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 6). (B) The concentration of PF4 in the supernatant of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 3). (C) Pf4 mRNA expression in differentiated CD45 − and CD45 + adipocytes ( n = 6). (D) Concentration of PF4 in the supernatant of differentiated CD45 − and CD45 + adipocytes ( n = 3). (E) Pf4 mRNA expression of BAT from Control and C5ar1 AKO neonatal mice ( n = 8). (F) Concentration of PF4 in BAT of Control and C5ar1 AKO neonatal mice ( n = 6). (G) Relative mRNA expression of the indicated genes of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 6). (H) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 3). (I) Relative mRNA expression of the indicated genes from adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (J) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (K) Graphical abstract of this study: The loss of C5ar1 in CD45 + adipocytes increased Pf4 mRNA level and increased the secretion of PF4. PF4 inhibited the maturity and thermogenesis ability of both CD45 + and CD45 − adipocytes. Statistical significance was assessed by two-tailed Student’s t test (A–G) or one-way ANOVA (I). Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.

Journal: iScience

Article Title: C5aR1-positive adipocytes mediate non-shivering thermogenesis in neonatal mice

doi: 10.1016/j.isci.2024.111261

Figure Lengend Snippet: C5ar1 knockdown in CD45 + brown adipocytes promote PF4 release to inhibit brown adipocyte maturation (A) Relative mRNA expression of the cytokines genes ( Pf4 , Ccl3 , Ccl4 , Ccl12 ) of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 6). (B) The concentration of PF4 in the supernatant of C5ar1 knockdown differentiated CD45 + adipocytes compared to the control group ( n = 3). (C) Pf4 mRNA expression in differentiated CD45 − and CD45 + adipocytes ( n = 6). (D) Concentration of PF4 in the supernatant of differentiated CD45 − and CD45 + adipocytes ( n = 3). (E) Pf4 mRNA expression of BAT from Control and C5ar1 AKO neonatal mice ( n = 8). (F) Concentration of PF4 in BAT of Control and C5ar1 AKO neonatal mice ( n = 6). (G) Relative mRNA expression of the indicated genes of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 6). (H) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured without or with 20 ng/mL PF4 ( n = 3). (I) Relative mRNA expression of the indicated genes from adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (J) Immunoblotting for UCP1 and PPARγ of adipocyte differentiation of CD45 − ASCs cultured in conditioned media from shNC, sh C5ar1 , sh Pf4 or sh C5ar1 + shPf4 CD45 + adipocytes ( n = 3). (K) Graphical abstract of this study: The loss of C5ar1 in CD45 + adipocytes increased Pf4 mRNA level and increased the secretion of PF4. PF4 inhibited the maturity and thermogenesis ability of both CD45 + and CD45 − adipocytes. Statistical significance was assessed by two-tailed Student’s t test (A–G) or one-way ANOVA (I). Data are represented as mean ± SEM ∗ ≤0.05, ∗∗ ≤0.01, ∗∗∗ ≤0.005.

Article Snippet: Recombinant mouse PF4 protein , MCE , Cat# HY-P71885.

Techniques: Knockdown, Expressing, Control, Concentration Assay, Cell Culture, Western Blot, Two Tailed Test

Journal: iScience

Article Title: C5aR1-positive adipocytes mediate non-shivering thermogenesis in neonatal mice

doi: 10.1016/j.isci.2024.111261

Figure Lengend Snippet:

Article Snippet: Recombinant mouse PF4 protein , MCE , Cat# HY-P71885.

Techniques: Recombinant, Enzyme-linked Immunosorbent Assay, cDNA Synthesis, SYBR Green Assay, Sequencing, Software

( A , B ) Megakaryocytes isolated from mice bone marrow, and infected with DENV2 (MOI ~ 1) for 24 h with and without 7D. Culture supernatant was used for measuring ( A ) CXCL4 levels using ELISA, and ( B ) cell pallet was used for detecting viral genome using qRT PCR, n = 3 independent experiments for both ( P values: A : 0.0002; 0.04, B : 0.0002; 0.008). ( C , D ) Similar experiment was performed in monocytes (as CXCL4 non-producing cells) isolated from whole blood of these mice. ( C ) CXCL4 and ( D ) DENV2 genome were detected, n = 3 independent experiments for both assays ( P value: 0.0002). A similar experiment was performed in ( E , F ) human MEG-01 cell line (CXCL4 producing cells), n = 3 independent experiments ( P values: E : 0.0008; 0.01, F : 0.006) and ( G , H ) U937-DC-SIGN cell line (CXCL4 non-producing cells), n = 3 independent experiments for above assays. One-way ANOVA and Bonferroni’s post-test were used for data analysis. Data information: ( A – E , G ) One-way ANOVA and Bonferroni’s post-test were used for data analysis. Data are mean ± SEM. ( F , H ) Student’s t-test was used. Data are mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns=non-significant.

Journal: EMBO Molecular Medicine

Article Title: 7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively

doi: 10.1038/s44321-024-00137-8

Figure Lengend Snippet: ( A , B ) Megakaryocytes isolated from mice bone marrow, and infected with DENV2 (MOI ~ 1) for 24 h with and without 7D. Culture supernatant was used for measuring ( A ) CXCL4 levels using ELISA, and ( B ) cell pallet was used for detecting viral genome using qRT PCR, n = 3 independent experiments for both ( P values: A : 0.0002; 0.04, B : 0.0002; 0.008). ( C , D ) Similar experiment was performed in monocytes (as CXCL4 non-producing cells) isolated from whole blood of these mice. ( C ) CXCL4 and ( D ) DENV2 genome were detected, n = 3 independent experiments for both assays ( P value: 0.0002). A similar experiment was performed in ( E , F ) human MEG-01 cell line (CXCL4 producing cells), n = 3 independent experiments ( P values: E : 0.0008; 0.01, F : 0.006) and ( G , H ) U937-DC-SIGN cell line (CXCL4 non-producing cells), n = 3 independent experiments for above assays. One-way ANOVA and Bonferroni’s post-test were used for data analysis. Data information: ( A – E , G ) One-way ANOVA and Bonferroni’s post-test were used for data analysis. Data are mean ± SEM. ( F , H ) Student’s t-test was used. Data are mean ± SEM. * P < 0.05, ** P < 0.01, *** P < 0.001, ns=non-significant.

Article Snippet: Human PF4 ELISA (Elabscience, USA).

Techniques: Isolation, Infection, Enzyme-linked Immunosorbent Assay, Quantitative RT-PCR

( A ) Sirtuin-1 (Sirt1) expression in Sirt1 −/− and WT mouse embryonic fibroblasts (MEFs) in western blot assay. Densitometry analysis independent experiments n = 3, Student’s t test was used ( P value: 0.005). Above cells were infected with DENV2 and treated with 7D as mentioned for U937-DC-SIGN in Fig. . After experiment, ( B ) WT and ( C ) Sirt1 −/− cells were used for western blot analysis for NS1, Ac-P53 and P-IRF3. ( D – I ) Densitometry data from, n = 3 independent experiments, one-way ANOVA and Bonferroni’s post-test were used ( P values: D : 0.04; 0.007; 0.01, E : 0.001, F : 0.009; 0.0002; 0.009, G : 0.005; 0.0008; 0.0006, I : 0.006; 0.002; 0.007). ( J , K ) Viral genome was quantified in WT and Sirt1 −/− MEFs pellet using qRT-PCR, n = 3 independent experiments, one-way ANOVA and Bonferroni’s post-test were used ( P values: J : 0.0013; 0.0007; 0.0005; 0.006, K : 0.004; 0.0004; 0.002; 0.003). ( L , M ) IFNα level was measured using ELISA from cell supernatant of above experiments, n = 3 independent experiments, one-way ANOVA and Bonferroni’s post-test were used ( P values: L : 0.003; 0.01; 0.0001; 0.0001, M : 0.0001; 0.0002; 0.0001; 0.0001). Data information: ( A , D – M ) Data are mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns=non-significant.

Journal: EMBO Molecular Medicine

Article Title: 7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively

doi: 10.1038/s44321-024-00137-8

Figure Lengend Snippet: ( A ) Sirtuin-1 (Sirt1) expression in Sirt1 −/− and WT mouse embryonic fibroblasts (MEFs) in western blot assay. Densitometry analysis independent experiments n = 3, Student’s t test was used ( P value: 0.005). Above cells were infected with DENV2 and treated with 7D as mentioned for U937-DC-SIGN in Fig. . After experiment, ( B ) WT and ( C ) Sirt1 −/− cells were used for western blot analysis for NS1, Ac-P53 and P-IRF3. ( D – I ) Densitometry data from, n = 3 independent experiments, one-way ANOVA and Bonferroni’s post-test were used ( P values: D : 0.04; 0.007; 0.01, E : 0.001, F : 0.009; 0.0002; 0.009, G : 0.005; 0.0008; 0.0006, I : 0.006; 0.002; 0.007). ( J , K ) Viral genome was quantified in WT and Sirt1 −/− MEFs pellet using qRT-PCR, n = 3 independent experiments, one-way ANOVA and Bonferroni’s post-test were used ( P values: J : 0.0013; 0.0007; 0.0005; 0.006, K : 0.004; 0.0004; 0.002; 0.003). ( L , M ) IFNα level was measured using ELISA from cell supernatant of above experiments, n = 3 independent experiments, one-way ANOVA and Bonferroni’s post-test were used ( P values: L : 0.003; 0.01; 0.0001; 0.0001, M : 0.0001; 0.0002; 0.0001; 0.0001). Data information: ( A , D – M ) Data are mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns=non-significant.

Article Snippet: Human PF4 ELISA (Elabscience, USA).

Techniques: Expressing, Western Blot, Infection, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay

( A ) Schematic representation of mice experiment. AG129 mice were intraperitonially (i.p.) infected with 10 5 FFU mouse-adapted DENV2 virus (P8- P23085 INDI-60) or incomplete L15 media as mock. 7D (8 mg/kg body weight) was administered (i.p.) till 4 days post-infection (DPI) and other half were injected with vehicle (PBS + 10%Tween 80) and euthanized at 6 DPI for following assays. ( B ) In a similar experiment, mice were observed till 15 DPI to obtain survival curves using the Kaplan–Meier method. The curve comparison analysis was performed between the DENV2 ( n = 12) and DENV2 + 7D ( n = 14). Log-rank (Mantle Cox) test was used for statistical analysis ( P value: 0.03). ( C ) Change in the body weight was recorded till 15 DPI, n = 7 vehicle, n = 8 mice per group, two-way ANOVA was used for data analysis, ( P values: 0.009; 0.0001; 0.0001). ( D ) Plasma CXCL4 levels from above mice was measured using ELISA at 6 DPI, n = 5 vehicle, n = 8 mice per group, one-way ANOVA and Kruskal–Wallis test were used, ( P value: 0.005). ( E , F ) DENV2 genome was quantified by qRT-PCR in ( E ) liver and ( F ) spleen tissues, respectively, n = 6 vehicle, n = 8 mice per group, one-way ANOVA and Bonferroni’s post-test were used, ( P values: E : 0.001; 0.004, F : 0.001; 0.005). ( G – M ) ( G ) Platelet, ( H ) monocytes, ( I ) neutrophil and ( J ) platelet-leukocyte aggregates were measured from peripheral blood of mice from above experiment using flow cytometry, n = 5 vehicle, n = 8 mice per group, one-way ANOVA and ( G , H : Kruskal–Wallis test) and ( I , J : Bonferroni’s post-test) were used, ( P values: G : 0.0005; 0.03, H : 0.003; 0.03, J : 0.0001; 0.005). Gating strategy is mentioned in Appendix Fig. . Plasma levels of ( K ) IL6, ( L ) TNFα and ( M ) IL1β were measured using CBA assay, n = 3 vehicle, n = 6 mice per group, Mann–Whitney U test was used, ( P values: K : 0.02; L : 0.03; M : 0.004). ( N , O ) Vascular leakage in mice blood vessels. ( N ) Image of Evan’s blue dye extravasation from the veins in abdominal region of DENV2-infected mice. ( O ) Quantification of Evan’s blue dye in different tissues, n = 5 vehicle, n = 5 for DENV2 and, n = 6 for DENV2 + 7D, two-way ANOVA was used, ( P values: 0.02; 0.03; 0.04). ( P – R ) Plasma ( P ) IFNα, ( Q ) IFNβ, n = 4 vehicle, n = 8 mice per group, and ( R ) IFNγ levels, n = 5 vehicle, n = 6 mice per group, were measured using ELISA, one-way ANOVA and Bonferroni’s post-test were used, ( P values: P : 0.006; 0.006; Q : 0.01; R : 0.03). Data information: ( C – J , O – R ) Data are mean ± SEM, and ( K – M ) median ± IQR, * P < 0.05, ** P < 0.01, *** P < 0.001, ns non-significant. .

Journal: EMBO Molecular Medicine

Article Title: 7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively

doi: 10.1038/s44321-024-00137-8

Figure Lengend Snippet: ( A ) Schematic representation of mice experiment. AG129 mice were intraperitonially (i.p.) infected with 10 5 FFU mouse-adapted DENV2 virus (P8- P23085 INDI-60) or incomplete L15 media as mock. 7D (8 mg/kg body weight) was administered (i.p.) till 4 days post-infection (DPI) and other half were injected with vehicle (PBS + 10%Tween 80) and euthanized at 6 DPI for following assays. ( B ) In a similar experiment, mice were observed till 15 DPI to obtain survival curves using the Kaplan–Meier method. The curve comparison analysis was performed between the DENV2 ( n = 12) and DENV2 + 7D ( n = 14). Log-rank (Mantle Cox) test was used for statistical analysis ( P value: 0.03). ( C ) Change in the body weight was recorded till 15 DPI, n = 7 vehicle, n = 8 mice per group, two-way ANOVA was used for data analysis, ( P values: 0.009; 0.0001; 0.0001). ( D ) Plasma CXCL4 levels from above mice was measured using ELISA at 6 DPI, n = 5 vehicle, n = 8 mice per group, one-way ANOVA and Kruskal–Wallis test were used, ( P value: 0.005). ( E , F ) DENV2 genome was quantified by qRT-PCR in ( E ) liver and ( F ) spleen tissues, respectively, n = 6 vehicle, n = 8 mice per group, one-way ANOVA and Bonferroni’s post-test were used, ( P values: E : 0.001; 0.004, F : 0.001; 0.005). ( G – M ) ( G ) Platelet, ( H ) monocytes, ( I ) neutrophil and ( J ) platelet-leukocyte aggregates were measured from peripheral blood of mice from above experiment using flow cytometry, n = 5 vehicle, n = 8 mice per group, one-way ANOVA and ( G , H : Kruskal–Wallis test) and ( I , J : Bonferroni’s post-test) were used, ( P values: G : 0.0005; 0.03, H : 0.003; 0.03, J : 0.0001; 0.005). Gating strategy is mentioned in Appendix Fig. . Plasma levels of ( K ) IL6, ( L ) TNFα and ( M ) IL1β were measured using CBA assay, n = 3 vehicle, n = 6 mice per group, Mann–Whitney U test was used, ( P values: K : 0.02; L : 0.03; M : 0.004). ( N , O ) Vascular leakage in mice blood vessels. ( N ) Image of Evan’s blue dye extravasation from the veins in abdominal region of DENV2-infected mice. ( O ) Quantification of Evan’s blue dye in different tissues, n = 5 vehicle, n = 5 for DENV2 and, n = 6 for DENV2 + 7D, two-way ANOVA was used, ( P values: 0.02; 0.03; 0.04). ( P – R ) Plasma ( P ) IFNα, ( Q ) IFNβ, n = 4 vehicle, n = 8 mice per group, and ( R ) IFNγ levels, n = 5 vehicle, n = 6 mice per group, were measured using ELISA, one-way ANOVA and Bonferroni’s post-test were used, ( P values: P : 0.006; 0.006; Q : 0.01; R : 0.03). Data information: ( C – J , O – R ) Data are mean ± SEM, and ( K – M ) median ± IQR, * P < 0.05, ** P < 0.01, *** P < 0.001, ns non-significant. .

Article Snippet: Human PF4 ELISA (Elabscience, USA).

Techniques: Infection, Virus, Injection, Comparison, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Quantitative RT-PCR, Flow Cytometry, MANN-WHITNEY

( A – D ) DENV2-specific antibodies ( A ) IgM at 3 DPI, and ( B ) IgG at 6 DPI were measured in mice plasma from the above experiments (Fig. ) using ELISA. A : n = 3 vehicle, n = 5 mice per group, one-way ANOVA and Bonferroni’s post-test, B : n = 4 vehicle, n = 8 DENV2, n = 9 DENV2 + 7D, Mann–Whitney U test was used, ( P values: A : 0.001; 0.03; B : 0.01). ( C ) FRNT 50 curves of neutralization activity of mice serum on DENV2 propagation in Vero cells, n = 3 vehicle, n = 10 mice per group. ( D ) Graph of the above values, n = 10 mice per group, Mann–Whitney U test was used ( P value: 0.02). Sera dilution assay is mentioned in Appendix Fig. . ( E ) Increased plasma cells (CD138 +ve B220 lo/-ve CD19 +ve ) percentage in 7D-treated mice spleen was measured using flow cytometry, n = 6 vehicle, n = 9 mice group, Kruskal–Wallis test is used ( P value: 0.02). ( F , G ) Spleenocytes from the above mice were used to quantitate DENV2-specific antibody secreting cells using ELISPOT assay, ( F ) representative image and ( G ) graph of the above values, n = 5 vehicle, n = 10 mice per group, one-way ANOVA and Bonferroni’s post-test were used ( P values: 0.0001; 0.04). ( H – J ) Intracellular levels of ( H , I ) Acetylated (Ac)-STAT3 and ( H , J ) phosphorylated ( P )-STAT3 in CD138 +ve cells was assessed by flow cytometry, n = 6 vehicle, n = 8 mice per group, one-way ANOVA and Bonferroni’s post-test were used ( P values: H : 0.0009; I : 0.001; 0.005; J : 0.001; 0.001). Gating strategy is mentioned in Appendix Fig. . ( K – M ) Western blot analysis of ( K , L ) Ac-STAT3 and ( K , M ) P-STAT3 from the spleenocytes normalized to β-actin. Densitometry of the above blots, n = 6 mice per group, one-way ANOVA and Bonferroni’s post-test were used ( P values: L : 0.001; M : 0.001). ( N , O ) Germinal center in spleen. ( N ) Immunofluorescent images of GL7-expressing follicles in spleen sections, GL7 (red) and DAPI (blue) staining. ( O ) Increased GL7-expressing follicles in 7D-treated mice, n = 8 mice per group, one-way ANOVA and Bonferroni’s post-test were used ( P values: 0.0001; 0.0002). Data information: ( A – C , E , G – J , L , M , O ) Data are mean ± SEM, and ( D ) median ± IQR, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns non-significant. Data from similar experiment in WT mice is described in Fig. . .

Journal: EMBO Molecular Medicine

Article Title: 7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively

doi: 10.1038/s44321-024-00137-8

Figure Lengend Snippet: ( A – D ) DENV2-specific antibodies ( A ) IgM at 3 DPI, and ( B ) IgG at 6 DPI were measured in mice plasma from the above experiments (Fig. ) using ELISA. A : n = 3 vehicle, n = 5 mice per group, one-way ANOVA and Bonferroni’s post-test, B : n = 4 vehicle, n = 8 DENV2, n = 9 DENV2 + 7D, Mann–Whitney U test was used, ( P values: A : 0.001; 0.03; B : 0.01). ( C ) FRNT 50 curves of neutralization activity of mice serum on DENV2 propagation in Vero cells, n = 3 vehicle, n = 10 mice per group. ( D ) Graph of the above values, n = 10 mice per group, Mann–Whitney U test was used ( P value: 0.02). Sera dilution assay is mentioned in Appendix Fig. . ( E ) Increased plasma cells (CD138 +ve B220 lo/-ve CD19 +ve ) percentage in 7D-treated mice spleen was measured using flow cytometry, n = 6 vehicle, n = 9 mice group, Kruskal–Wallis test is used ( P value: 0.02). ( F , G ) Spleenocytes from the above mice were used to quantitate DENV2-specific antibody secreting cells using ELISPOT assay, ( F ) representative image and ( G ) graph of the above values, n = 5 vehicle, n = 10 mice per group, one-way ANOVA and Bonferroni’s post-test were used ( P values: 0.0001; 0.04). ( H – J ) Intracellular levels of ( H , I ) Acetylated (Ac)-STAT3 and ( H , J ) phosphorylated ( P )-STAT3 in CD138 +ve cells was assessed by flow cytometry, n = 6 vehicle, n = 8 mice per group, one-way ANOVA and Bonferroni’s post-test were used ( P values: H : 0.0009; I : 0.001; 0.005; J : 0.001; 0.001). Gating strategy is mentioned in Appendix Fig. . ( K – M ) Western blot analysis of ( K , L ) Ac-STAT3 and ( K , M ) P-STAT3 from the spleenocytes normalized to β-actin. Densitometry of the above blots, n = 6 mice per group, one-way ANOVA and Bonferroni’s post-test were used ( P values: L : 0.001; M : 0.001). ( N , O ) Germinal center in spleen. ( N ) Immunofluorescent images of GL7-expressing follicles in spleen sections, GL7 (red) and DAPI (blue) staining. ( O ) Increased GL7-expressing follicles in 7D-treated mice, n = 8 mice per group, one-way ANOVA and Bonferroni’s post-test were used ( P values: 0.0001; 0.0002). Data information: ( A – C , E , G – J , L , M , O ) Data are mean ± SEM, and ( D ) median ± IQR, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns non-significant. Data from similar experiment in WT mice is described in Fig. . .

Article Snippet: Human PF4 ELISA (Elabscience, USA).

Techniques: Clinical Proteomics, Enzyme-linked Immunosorbent Assay, MANN-WHITNEY, Neutralization, Activity Assay, Dilution Assay, Flow Cytometry, Enzyme-linked Immunospot, Western Blot, Expressing, Staining

DENV2 infection experiment was performed in bone marrow derived macrophages (BMDMs), isolated from AG129 mice, in presence of 7D. A blocking antibody to IFNλ2/3 (5 µg/ml, standardization of working concentration is mentioned in Fig. EV4L below) was used to investigate the effects of type-III IFN. ( A ) Viral genome was quantified in cell pellets using qRT-PCR, n = 3 independent experiments ( P values: 0.0011; 0.0002; 0.03; 0.0014). ( B – E ) Relative gene expressions of interferon-stimulated genes (ISGs), ( B ) Oas1a, ( C ) Isg15, ( D ) Trim69, and ( E ) Mx1 were measured from above experiments, n = 3 independent experiments, ( P values: B : 0.0001; 0.0013; 0.0001; 0.0001, C : 0.0001; 0.0001; 0.0012; 0.01; 0.0001, D : 0.0006; 0.01; 0.0008; 0.0001, E : 0.0001; 0.0001; 0.0014; 0.009; 0.0001). ( F ) IFN λ2/3 levels were measured in the supernatant of these cells using ELISA, n = 3 independent experiments, ( P values: 0.004; 0.02; 0.002). ( G , H ) Relative gene expressions of ifnl2 and ifnl3 were quantified from the above cell pellets, n = 3 independent experiments, ( P values: G : 0.001; 0.001; 0.008, H : 0.001; 0.003; 0.001). ( I – K ) Western blot analysis for P-p38:p38 and P-IRF3:IRF3. ( J , K ) Densitometry data from, n = 3 independent experiments, ( P values: J : 0.007; 0.003; 0.001, K : 0.0006; 0.0002; 0.0003). ( L ) Concentration-dependent effect of blocking antibody against type-III IFN was tested on viral replication. DENV2 mRNA was quantified from pellets of DENV2-infected U937-DC-SIGN cells in presence of increasing concentration (1, 5 and 10 µg/ml) of blocking antibody against IFN-λ2/3 Ab, n = 3 independent experiments, ( P values: 0.001; 0.002; 0.0002). One-way ANOVA and Bonferroni’s post-test were used for above analysis. Data information: ( A – H , J – L ) One-way ANOVA and Bonferroni’s post-test were used. Data are mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns=non-significant.

Journal: EMBO Molecular Medicine

Article Title: 7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively

doi: 10.1038/s44321-024-00137-8

Figure Lengend Snippet: DENV2 infection experiment was performed in bone marrow derived macrophages (BMDMs), isolated from AG129 mice, in presence of 7D. A blocking antibody to IFNλ2/3 (5 µg/ml, standardization of working concentration is mentioned in Fig. EV4L below) was used to investigate the effects of type-III IFN. ( A ) Viral genome was quantified in cell pellets using qRT-PCR, n = 3 independent experiments ( P values: 0.0011; 0.0002; 0.03; 0.0014). ( B – E ) Relative gene expressions of interferon-stimulated genes (ISGs), ( B ) Oas1a, ( C ) Isg15, ( D ) Trim69, and ( E ) Mx1 were measured from above experiments, n = 3 independent experiments, ( P values: B : 0.0001; 0.0013; 0.0001; 0.0001, C : 0.0001; 0.0001; 0.0012; 0.01; 0.0001, D : 0.0006; 0.01; 0.0008; 0.0001, E : 0.0001; 0.0001; 0.0014; 0.009; 0.0001). ( F ) IFN λ2/3 levels were measured in the supernatant of these cells using ELISA, n = 3 independent experiments, ( P values: 0.004; 0.02; 0.002). ( G , H ) Relative gene expressions of ifnl2 and ifnl3 were quantified from the above cell pellets, n = 3 independent experiments, ( P values: G : 0.001; 0.001; 0.008, H : 0.001; 0.003; 0.001). ( I – K ) Western blot analysis for P-p38:p38 and P-IRF3:IRF3. ( J , K ) Densitometry data from, n = 3 independent experiments, ( P values: J : 0.007; 0.003; 0.001, K : 0.0006; 0.0002; 0.0003). ( L ) Concentration-dependent effect of blocking antibody against type-III IFN was tested on viral replication. DENV2 mRNA was quantified from pellets of DENV2-infected U937-DC-SIGN cells in presence of increasing concentration (1, 5 and 10 µg/ml) of blocking antibody against IFN-λ2/3 Ab, n = 3 independent experiments, ( P values: 0.001; 0.002; 0.0002). One-way ANOVA and Bonferroni’s post-test were used for above analysis. Data information: ( A – H , J – L ) One-way ANOVA and Bonferroni’s post-test were used. Data are mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001 and ns=non-significant.

Article Snippet: Human PF4 ELISA (Elabscience, USA).

Techniques: Infection, Derivative Assay, Isolation, Blocking Assay, Concentration Assay, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Western Blot

As mentioned in the above Fig. , a similar experiment was performed in CXCR3 −/− and WT C57BL/6 mice at 6 DPI. ( A , B ) Spleen was isolated and processed for measuring dengue viral genome copies were quantified in ( A ) CXCR3 −/− , n = 5 vehicle, n = 7 mice per group, one-way ANOVA and Kruskal–Wallis test, ( P values: 0.0002; 0.03), and ( B ) WT, n = 6 vehicle, n = 7 mice per group, one-way ANOVA and Bonferroni’s post-test, ( P values: 0.004; 0.04) using qRT-PCR. ( C , D ) IFNα levels were measured in plasma of these mice (C) CXCR3 −/− , n = 5 vehicle, n = 7 mice per group, and ( D ) WT, n = 6 vehicle, n = 9 mice per group, one-way ANOVA and Bonferroni’s post-test were used for both cases, ( P values: C : 0.0003, D : 0.01). ( E , F ) DENV2-specific IgG levels were measured in mice plasma of ( E ) CXCR3 −/− , n = 5 vehicle, n = 7 mice per group, and ( F ) WT, n = 5 vehicle, n = 6 mice per group, using ELISA. One-way ANOVA and Bonferroni’s post-test were used for both cases, ( P values: E : 0.003; 0.0013, F : 0.001). ( G – J ) FRNT 50 curves and graph of neutralization activity of mice plasma was measured in ( G , H ) CXCR3 −/− , n = 3 vehicle, n = 7 mice per group, and ( I , J ) WT, n = 6 vehicle, n = 7 mice per group. Mann–Whitney U test was used for analysis for both cases, ( P value: 0.003). Sera dilution assay is mentioned in Appendix Fig. . Data information: ( A – F , G , I ) Data are mean ± SEM, and ( H , J ) median ± IQR, * P < 0.05, ** P < 0.01, ns non-significant. .

Journal: EMBO Molecular Medicine

Article Title: 7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively

doi: 10.1038/s44321-024-00137-8

Figure Lengend Snippet: As mentioned in the above Fig. , a similar experiment was performed in CXCR3 −/− and WT C57BL/6 mice at 6 DPI. ( A , B ) Spleen was isolated and processed for measuring dengue viral genome copies were quantified in ( A ) CXCR3 −/− , n = 5 vehicle, n = 7 mice per group, one-way ANOVA and Kruskal–Wallis test, ( P values: 0.0002; 0.03), and ( B ) WT, n = 6 vehicle, n = 7 mice per group, one-way ANOVA and Bonferroni’s post-test, ( P values: 0.004; 0.04) using qRT-PCR. ( C , D ) IFNα levels were measured in plasma of these mice (C) CXCR3 −/− , n = 5 vehicle, n = 7 mice per group, and ( D ) WT, n = 6 vehicle, n = 9 mice per group, one-way ANOVA and Bonferroni’s post-test were used for both cases, ( P values: C : 0.0003, D : 0.01). ( E , F ) DENV2-specific IgG levels were measured in mice plasma of ( E ) CXCR3 −/− , n = 5 vehicle, n = 7 mice per group, and ( F ) WT, n = 5 vehicle, n = 6 mice per group, using ELISA. One-way ANOVA and Bonferroni’s post-test were used for both cases, ( P values: E : 0.003; 0.0013, F : 0.001). ( G – J ) FRNT 50 curves and graph of neutralization activity of mice plasma was measured in ( G , H ) CXCR3 −/− , n = 3 vehicle, n = 7 mice per group, and ( I , J ) WT, n = 6 vehicle, n = 7 mice per group. Mann–Whitney U test was used for analysis for both cases, ( P value: 0.003). Sera dilution assay is mentioned in Appendix Fig. . Data information: ( A – F , G , I ) Data are mean ± SEM, and ( H , J ) median ± IQR, * P < 0.05, ** P < 0.01, ns non-significant. .

Article Snippet: Human PF4 ELISA (Elabscience, USA).

Techniques: Isolation, Quantitative RT-PCR, Clinical Proteomics, Enzyme-linked Immunosorbent Assay, Neutralization, Activity Assay, MANN-WHITNEY, Dilution Assay

As mentioned in the Fig. , a similar experiment was performed in AG129 mice treated with 7D and STAT3-inhibitor Stattic (10 mg/kg/body weight, referred concentration from vendor’s manual). ( A , B ) DENV2 viral RNA was quantified in liver and spleen respectively using qRT-PCR, n = 8 mice per group, ( P values: A : 0.0001; 0.0001; 0.003, B : 0.0001; 0.0003; 0.04). ( C , D ) Anti-dengue IgG was measured from the serum of mice using ELISA, n = 8, ( P values: 0.0001; 0.0005; 0.003). ( E – G ) Ac-STAT3 and P-STAT3 were measured in spleenocytes by western blot and normalized with total STAT3. Densitometry of the above blots, n = 4 vehicle, n = 6 mice per group ( P values: F : 0.0008; 0.0001, G : 0.01). One-way ANOVA and Bonferroni’s post-test were used for all above analysis. Data information: ( A – D , F , G ) One-way ANOVA and Bonferroni’s post-test were used. Data are mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns=non-significant.

Journal: EMBO Molecular Medicine

Article Title: 7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively

doi: 10.1038/s44321-024-00137-8

Figure Lengend Snippet: As mentioned in the Fig. , a similar experiment was performed in AG129 mice treated with 7D and STAT3-inhibitor Stattic (10 mg/kg/body weight, referred concentration from vendor’s manual). ( A , B ) DENV2 viral RNA was quantified in liver and spleen respectively using qRT-PCR, n = 8 mice per group, ( P values: A : 0.0001; 0.0001; 0.003, B : 0.0001; 0.0003; 0.04). ( C , D ) Anti-dengue IgG was measured from the serum of mice using ELISA, n = 8, ( P values: 0.0001; 0.0005; 0.003). ( E – G ) Ac-STAT3 and P-STAT3 were measured in spleenocytes by western blot and normalized with total STAT3. Densitometry of the above blots, n = 4 vehicle, n = 6 mice per group ( P values: F : 0.0008; 0.0001, G : 0.01). One-way ANOVA and Bonferroni’s post-test were used for all above analysis. Data information: ( A – D , F , G ) One-way ANOVA and Bonferroni’s post-test were used. Data are mean ± SEM, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001, ns=non-significant.

Article Snippet: Human PF4 ELISA (Elabscience, USA).

Techniques: Concentration Assay, Quantitative RT-PCR, Enzyme-linked Immunosorbent Assay, Western Blot

Reagents and tools table

Journal: EMBO Molecular Medicine

Article Title: 7D, a small molecule inhibits dengue infection by increasing interferons and neutralizing-antibodies via CXCL4:CXCR3:p38:IRF3 and Sirt1:STAT3 axes respectively

doi: 10.1038/s44321-024-00137-8

Figure Lengend Snippet: Reagents and tools table

Article Snippet: Human PF4 ELISA (Elabscience, USA).

Techniques: Isolation, Sequencing, Enzyme-linked Immunosorbent Assay, SYBR Green Assay, Lysis, Plasmid Preparation, Software, Real-time Polymerase Chain Reaction